IPO Boutique Research, Color & More Information for Subscribers
This content is restricted to IPO Boutique Subscribers Username or E-mail: Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual[…]
This content is restricted to IPO Boutique Subscribers Username or E-mail: Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual[…]
This content is restricted to IPO Boutique Subscribers Username or E-mail: Become a Subscriber Disclaimer IPO Boutique aggregates information on public companies and private companies, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual[…]
Company: AVROBIO, Inc. Symbol: AVRO Description: They are a clinical stage gene therapy company focused on developing potentially curative ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose. Trade Date: 6/21 Shares: 4.4 million Price Range: $16.00-$18.00 Underwriter(s): Morgan Stanley, Cowen, Wells Fargo Securities Co-Manager(s): Wedbush Pacgrow Terms Added: 6-11-18 Link[…]